Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PCRX · against 414 other Healthcare companies of similar size
Ranked #96 of 415 · scores higher than 76% of peers
Bars: peers in each 10-point band of the growth score42 peers with a growth score of 70–79, including PCRX · Click a bar to see the companies
Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
| Metric | PCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 419 reported | 5.7% | 5.4% | 50% | 33% | |
| Earnings per share growthHigher is better · 227 reported | Not reported | 8.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 407 reported | 3.7% | 6.4% | 41% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 96 | 748M USD | 76 | 62 | |
| 96 | 1.1B CAD (≈$807M) | 76 | 60 | |
| 96 | 1.2B USD | 76 | 39 | |
| 96 | 660M GBP (≈$858M) | 76 | 35 | |
| 96 | 1.5B USD | 76 | 59 | |
| 101 | 1.2B USD | 75 | 36 | |
| 101 | 2.9B USD | 75 | 50 | |
| 101 | 31.3B TRY (≈$938M) | 75 | 50 | |
| 101 | 2.2B USD | 75 | 78 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score